A community from npj Precision Oncology

Nature Cancer

Glass half full: Improving outcomes in patients with circulating tumor DNA molecular residual disease

Contributor, Nature Cancer

Behind the paper

Glass half full: Improving outcomes in patients with circulating tumor DNA molecular residual disease

Everett J Moding

Jan 20, 2020

Studying the T cell repertoire and risk of melanoma progression

Contributor, Nature Cancer

Behind the paper

Studying the T cell repertoire and risk of melanoma progression

Wiebke Pruessmann

Jan 20, 2020

Nature Cancer is now live

Nature Research, Nature Cancer

Nature Cancer is now live

Jan 17, 2020

Contributor, Nature Cancer

Behind the paper

Population differences in tumor biology and the importance of including minority populations in genomics research

Brid Mairead Ryan

Jan 15, 2020

Studying the genomic wiring of response to immune checkpoint blockade

Contributor, Nature Cancer

Behind the paper

Studying the genomic wiring of response to immune checkpoint blockade

Valsamo Anagnostou

Jan 14, 2020

Contributor Nature Cancer

Behind the paper

Reversing cancer immune exclusion with PAK4 inhibition

Gabriel Abril-Rodriguez and Antoni Ribas

Gabriel Abril-Rodriguez

Dec 11, 2019

Alterations of ubiquitin-mediated proteolysis in cancer

Contributor Nature Cancer

Behind the paper

Alterations of ubiquitin-mediated proteolysis in cancer

Abel Gonzalez-Perez

Dec 03, 2019

Meet our Chief Editor

Nature Research, Nature Cancer

Meet our Chief Editor

Nov 20, 2019

Contributor Nature Cancer

Behind the paper

Connecting the dots: adapting innovative antibody technology to improve cancer immunotherapy

Turns out there are times when it’s important to improve on mother nature, especially when confronting a life-threatening disease.

Nov 19, 2019

Add your journal name with a clickable badge

Nature Research, Nature Cancer

About the community

Add your journal name with a clickable badge

Oct 17, 2019